Abrax Japan, Inc.

About

Abrax is a biopharmaceutical company that is focused on modulating one's immune system by promoting the skin to produce a cytokine called TSLP. The company's initial focus is to develop a repurposed topical product for atopic dermatitis while leveraging the concomitant findings to generate new molecular entities for a wide array of autoimmune indications.